Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse 4-1BB/TNFRSF9/CD137 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB9372RSP
This item is not returnable.
View return policy
Description
4-1BB/TNFRSF9/CD137 Monoclonal specifically detects 4-1BB/TNFRSF9/CD137 in Mouse samples. It is validated for Blockade of Receptor-ligand Interaction.Specifications
| 4-1BB/TNFRSF9/CD137 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| 41BB, 4-1BB, 4-1BB ligand receptor, CD137, CD137 antigen, CD137MGC2172, CDw137, FLJ43501, ILA, ILAhomolog of mouse 4-1BB, induced by lymphocyte activation (ILA), interleukin-activated receptor, homolog of mouse Ly63, receptor protein 4-1BB, T cell antigen ILA, T-cell antigen 4-1BB homolog, T-cell antigen ILA, TNFRSF9, tumor necrosis factor receptor superfamily member 9, tumor necrosis factor receptor superfamily, member 9 | |
| Mouse myeloma cell line NS0-derived recombinant mouse 4-1BB Val24-Leu187 Accession # P20334 | |
| 25 μg | |
| 3604 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2b |
| Blockade of Receptor-ligand Interaction | |
| 158306R | |
| Blockade of Receptor-ligand Interaction | |
| P20334 | |
| Rat | |
| Protein A or G purified from cell culture supernatant | |
| Primary | |
| Detects mouse 4-1BB in direct ELISAs. | |
| Mouse | |
| Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction